IN BRIEF: Surgical Innovations Unit Launches Breast Reconstruction Range

Wed, 02nd Dec 2020 14:24

Surgical Innovations Group PLC - Leeds-based manufacturer of medical products for minimally invasive surgery - Says subsidiary Elemental Healthcare Ltd launches Cellis Breast, a new biological matrix range for breast reconstruction. Notes UK market for biological models for breast reconstruction is worth around GBP16 million and it therefore expects Cellis Breast to gain market share as reconstructive surgery resumes following deferrals due to Covid-19.

Current stock price: 1.48 pence

Year-to-date change: down 28%

By Ife Taiwo; ifetaiwo@alliancenews.com

Related Shares

More News

18 Apr 2024 16:52

LONDON MARKET CLOSE: Stocks recover some of recent Fed talk losses

(Alliance News) - Stock prices in London closed up on Thursday, despite the prospect of higher for longer US interest rates hanging over stocks, while...

18 Apr 2024 10:49

AIM WINNERS & LOSERS: Surgical Innovations up as revenue jumps

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

18 Apr 2024 10:47

Surgical Innovations sets sights on future growth after record revenue

(Alliance News) - Shares in Surgical Innovations Group PLC rose on Thursday, as the company released its results for the past year and announced the s...

9 Apr 2024 13:44

Surgical Innovations confirms CFO Charmaine Day's departure

(Alliance News) - Surgical Innovations Group PLC on Tuesday confirmed that Charmaine Day has stepped down as its finance chief.

9 Apr 2024 09:30

AIM WINNERS & LOSERS: Tern rises on Talking Medicines quarterly update

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.